Literature DB >> 10640648

Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery.

M H Sheridan1, L D Shea, M C Peters, D J Mooney.   

Abstract

Engineering new tissues utilizing cell transplantation on biodegradable polymer matrices is an attractive approach to treat patients suffering from the loss or dysfunction of a number of tissues and organs. The matrices must maintain structural integrity during the process of tissue formation, and promote the vascularization of the developing tissue. A number of molecules (angiogenic factors) have been identified that promote the formation of new vascular beds from endothelial cells present within tissues, and the localized, controlled delivery of these factors from a matrix may allow an enhanced vascularization of engineered tissues. We have developed a gas foaming polymer processing approach that allows the fabrication of three-dimensional porous matrices from bioabsorbable materials (e.g., copolymers of lactide and glycolide [PLG]) without the use of organic solvents or high temperatures. The effects of several processing parameters (e.g., gas type, polymer composition and molecular weight) on the process were studied. Several gases (CO(2), N(2), He) were utilized in the fabrication process, but only CO(2) resulted in the formation of highly porous, structurally intact matrices. Crystalline polymers (polylactide and polyglycolide) did not form porous matrices, while amorphous copolymers (50:50, 75:25, and 85:15 ratio of lactide:glycolide) foamed to yield matrices with porosity up to 95%. The mechanical properties of matrices were also regulated by the choice of PLG composition and molecular weight. Angiogenic factors (e.g., vascular endothelial growth factor) were subsequently incorporated into matrices during the fabrication process, and released in a controlled manner. Importantly, the released growth factor retains over 90% of its bioactivity. In summary, a promising system for the incorporation and delivery of angiogenic factors from three-dimensional, biodegradable polymer matrices has been developed, and the fabrication process allows incorporation under mild conditions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10640648     DOI: 10.1016/s0168-3659(99)00138-8

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  59 in total

1.  Vascular endothelial growth factor and fibroblast growth factor 2 delivery from spinal cord bridges to enhance angiogenesis following injury.

Authors:  Laura De Laporte; Anne des Rieux; Hannah M Tuinstra; Marina L Zelivyanskaya; Nora M De Clerck; Andrei A Postnov; Véronique Préat; Lonnie D Shea
Journal:  J Biomed Mater Res A       Date:  2011-05-31       Impact factor: 4.396

Review 2.  Designer blood vessels and therapeutic revascularization.

Authors:  Joseph D Berglund; Zorina S Galis
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

Review 3.  Angiogenic therapy for cardiac repair based on protein delivery systems.

Authors:  F R Formiga; E Tamayo; T Simón-Yarza; B Pelacho; F Prósper; M J Blanco-Prieto
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

Review 4.  Growth factor delivery-based tissue engineering: general approaches and a review of recent developments.

Authors:  Kangwon Lee; Eduardo A Silva; David J Mooney
Journal:  J R Soc Interface       Date:  2010-08-18       Impact factor: 4.118

5.  Mimicking nature by codelivery of stimulant and inhibitor to create temporally stable and spatially restricted angiogenic zones.

Authors:  William W Yuen; Nan R Du; Chun H Chan; Eduardo A Silva; David J Mooney
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

Review 6.  Inductive tissue engineering with protein and DNA-releasing scaffolds.

Authors:  David M Salvay; Lonnie D Shea
Journal:  Mol Biosyst       Date:  2005-11-25

7.  Silk fibroin/chitosan scaffold: preparation, characterization, and culture with HepG2 cell.

Authors:  Zhending She; Chenrui Jin; Zhi Huang; Bofeng Zhang; Qingling Feng; Yingxin Xu
Journal:  J Mater Sci Mater Med       Date:  2008-07-15       Impact factor: 3.896

8.  Induction of angiogenesis in tissue-engineered scaffolds designed for bone repair: a combined gene therapy-cell transplantation approach.

Authors:  Ehsan Jabbarzadeh; Trevor Starnes; Yusuf M Khan; Tao Jiang; Anthony J Wirtel; Meng Deng; Qing Lv; Lakshmi S Nair; Steven B Doty; Cato T Laurencin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-04       Impact factor: 11.205

9.  In vitro and in vivo release of vascular endothelial growth factor from gelatin microparticles and biodegradable composite scaffolds.

Authors:  Zarana S Patel; Hiroki Ueda; Masaya Yamamoto; Yasuhiko Tabata; Antonios G Mikos
Journal:  Pharm Res       Date:  2008-07-29       Impact factor: 4.200

10.  Experimental study of epidermal growth factor and acidic fibroblast growth factor in the treatment of diabetic foot wounds.

Authors:  Jiasheng Xu; Dinghong Min; Guanghua Guo; Xincheng Liao; Zhonghua Fu
Journal:  Exp Ther Med       Date:  2018-05-03       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.